MA51199A - Agents d'imagerie - Google Patents

Agents d'imagerie

Info

Publication number
MA51199A
MA51199A MA051199A MA51199A MA51199A MA 51199 A MA51199 A MA 51199A MA 051199 A MA051199 A MA 051199A MA 51199 A MA51199 A MA 51199A MA 51199 A MA51199 A MA 51199A
Authority
MA
Morocco
Prior art keywords
imaging agents
imaging
agents
Prior art date
Application number
MA051199A
Other languages
English (en)
Inventor
Ralph Maguire
Joël Mercier
Anne Valade
Celine Vermeiren
Martyn Wood
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of MA51199A publication Critical patent/MA51199A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nuclear Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA051199A 2017-12-01 2018-11-27 Agents d'imagerie MA51199A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17204896 2017-12-01

Publications (1)

Publication Number Publication Date
MA51199A true MA51199A (fr) 2020-10-07

Family

ID=60574412

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051199A MA51199A (fr) 2017-12-01 2018-11-27 Agents d'imagerie

Country Status (11)

Country Link
US (3) US20200369675A1 (fr)
EP (1) EP3717025B1 (fr)
JP (1) JP7341139B2 (fr)
CN (1) CN111432847A (fr)
BR (1) BR112020009876A2 (fr)
CA (1) CA3083329A1 (fr)
DK (1) DK3717025T3 (fr)
EA (1) EA202091323A1 (fr)
ES (1) ES2899679T3 (fr)
MA (1) MA51199A (fr)
WO (1) WO2019105913A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI809597B (zh) * 2020-12-16 2023-07-21 美商美國禮來大藥廠 預靶向造影劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003285928A1 (en) * 2002-10-22 2004-05-13 Drugabuse Sciences S.A.S. Treatment of cognitive impairment using a selective dopamine d1 receptor agonist
WO2010015340A1 (fr) * 2008-08-06 2010-02-11 Bayer Schering Pharma Aktiengesellschaft Daa-pyridine comme ligand des récepteurs périphériques des benzodiazépines pour l'imagerie de diagnostic et le traitement pharmaceutique
SG11201502763VA (en) 2012-11-08 2015-05-28 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands
JO3316B1 (ar) * 2013-05-30 2019-03-13 Lilly Co Eli مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل
BR112017007123B1 (pt) 2014-10-08 2023-01-31 Ucb Biopharma Sprl Composto representado pela fórmula (i-a), ou um seu sal farmaceuticamente aceitável, uso de um composto de fórmula (ia) e composição farmacêutica

Also Published As

Publication number Publication date
CA3083329A1 (fr) 2019-06-06
JP7341139B2 (ja) 2023-09-08
ES2899679T3 (es) 2022-03-14
DK3717025T3 (da) 2021-11-22
US20200369675A1 (en) 2020-11-26
JP2021504426A (ja) 2021-02-15
BR112020009876A2 (pt) 2020-11-03
EP3717025A1 (fr) 2020-10-07
US20220162221A1 (en) 2022-05-26
EA202091323A1 (ru) 2020-10-09
CN111432847A (zh) 2020-07-17
EP3717025B1 (fr) 2021-11-03
WO2019105913A1 (fr) 2019-06-06
US20240343737A1 (en) 2024-10-17

Similar Documents

Publication Publication Date Title
EP3734660A4 (fr) Élément d'imagerie
DK3687994T3 (da) Gadolinium-bærende pcta-baserede kontrastmidler
EP3665702A4 (fr) Rapport d'imagerie médicale quantitative
EP3721620A4 (fr) Projecteur d'image
EP3430731A4 (fr) Architecture d'iugw
EP3544492A4 (fr) Gestionnaire de protocoles d'imagerie
EP3607587A4 (fr) Panneau d'affichage
EP3508814A4 (fr) Dispositif d'imagerie
EP3437540A4 (fr) Support d'endoscope
EP3585446A4 (fr) Marqueurs d'imagerie multi-mode
EP3379317A4 (fr) Lentille d'imagerie
EP3530828A4 (fr) Raccord d'articulation
EP3413015A4 (fr) Dispositif d'imagerie
EP3618723A4 (fr) Cathéter d'imagerie
EP3396937A4 (fr) Dispositif d'imagerie
EP3343912A4 (fr) Dispositif d'imagerie
EP3427023A4 (fr) Agencement d'imagerie hyperspectrale
EP3405821A4 (fr) Inverseur d'image fovéale
EP3482698A4 (fr) Instrument d'hémostase
EP3431808A4 (fr) Butée d'arrêt
EP3664438A4 (fr) Dispositif d'imagerie
EP3338446A4 (fr) Projections d'image
EP3761922C0 (fr) Support d'épaule orthétique
EP3470917A4 (fr) Dispositif d'imagerie
EP3627218A4 (fr) Dispositif d'imagerie